SERUM ALBUMIN LEVELS AS A SURROGATE MARKER FOR DOCETAXEL INDUCED TOXICITY IN NONMETASTATIC BREAST CANCER PATIENTS

被引：0
|
作者：
Jain, A. [1 ]
Bapsy, P. P. [2 ]
机构：
[1] Reg Canc Ctr, JIPMER, Dept Med Oncol, Pondicherry, India
[2] Apollo Hosp, Dept Med Oncol, Bangalore, Karnataka, India
来源：
ANNALS OF ONCOLOGY | 2010年 / 21卷
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
引用
收藏
页码：400 / 400
页数：1
相关论文
共 50 条
  • [31] SERUM OSTEOCALCIN LEVELS IN BREAST-CANCER PATIENTS
    PIETSCHMANN, P
    ZIELINSKI, C
    WOLOSZCZUK, W
    JOURNAL OF CANCER RESEARCH AND CLINICAL ONCOLOGY, 1989, 115 (05) : 456 - 458
  • [32] Preoperative serum leptin levels in patients with breast cancer
    Mehmet Aliustaoglu
    Ahmet Bilici
    Mahmut Gumus
    Aslihan Topal Colak
    Gulcan Baloglu
    Rahmi Irmak
    Mesut Seker
    Bala Basak Oven Ustaalioglu
    Tarik Salman
    Berkant Sonmez
    Taflan Salepci
    Mustafa Yaylaci
    Medical Oncology, 2010, 27 : 388 - 391
  • [33] SERUM FERRITIN LEVELS IN PATIENTS WITH BREAST-CANCER
    MARCUS, DM
    ZINBERG, N
    CLINICAL RESEARCH, 1975, 23 (03): : A447 - A447
  • [34] Low serum albumin levels and high neutrophil counts are predictive of a poorer prognosis in patients with metastatic breast cancer
    Xiang, Mengqi
    Zhang, Huachuan
    Tian, Jinjun
    Yuan, Yihang
    Xu, Zhihua
    Chen, Jing
    ONCOLOGY LETTERS, 2022, 24 (06)
  • [35] Serum Albumin and Prealbumin Do Not Predict Recurrence in Patients with Breast Cancer
    Fujii, Takaaki
    Yajima, Reina
    Takada, Takahiro
    Sutoh, Toshinaga
    Morita, Hiroki
    Yamaguchi, Satoru
    Tsutsumi, Soichi
    Kuwano, Hiroyuki
    ANTICANCER RESEARCH, 2014, 34 (07) : 3775 - 3779
  • [36] Serum uric acid levels: A surrogate marker of oxidative stress or dehydration?
    Ito, Hiroshi
    EUROPEAN JOURNAL OF INTERNAL MEDICINE, 2021, 86 : 110 - 110
  • [37] Influence of amifostine on the toxicity and pharmacokinetics of docetaxel in metastatic breast cancer patients: A pilot study
    Freyer, G
    Hennebert, P
    Awada, A
    Gil, T
    Kerger, J
    Selleslags, J
    Brassinne, C
    Piccart, M
    de Valeriola, D
    CLINICAL CANCER RESEARCH, 2002, 8 (01) : 95 - 102
  • [38] Clinical experience with docetaxel for Chinese breast cancer patients: hematological toxicity profiles.
    Yip A.Y.
    Chow L.W.
    Breast Cancer, 2006, 13 (2) : 192 - 196
  • [39] Skin toxicity as a risk factor for major infections in breast cancer patients treated with docetaxel
    Poikonen, P
    Sjöström, J
    Klaar, S
    Nittby, LT
    Sigurdsson, H
    Madsen, EL
    Joensuu, H
    Blomqvist, C
    ACTA ONCOLOGICA, 2004, 43 (02) : 190 - 195
  • [40] Adjuvant docetaxel and cyclofosfamide in breast cancer patients over 65 years: compliance and toxicity
    Serrano, C.
    Cortes, J.
    Russillo, M.
    Bellet, M.
    Gomez, R.
    Saura, C.
    Perez, J.
    Farriols, A.
    Baselga, J.
    Di Cosimo, S.
    EJC SUPPLEMENTS, 2009, 7 (02): : 218 - 218
12345